NeuPath Health Inc.
NPTH.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 51.99M | 51.11M | 50.08M | 48.99M | 48.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.99M | 51.11M | 50.08M | 48.99M | 48.48M |
| Cost of Revenue | 42.09M | 41.38M | 40.71M | 39.87M | 39.67M |
| Gross Profit | 9.90M | 9.73M | 9.37M | 9.11M | 8.81M |
| SG&A Expenses | 7.26M | 7.15M | 7.00M | 6.86M | 6.69M |
| Depreciation & Amortization | 1.80M | 1.85M | 1.90M | 1.93M | 1.88M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.16M | 50.38M | 49.61M | 48.66M | 48.24M |
| Operating Income | 835.30K | 732.80K | 474.10K | 328.70K | 240.30K |
| Income Before Tax | -378.80K | 186.00K | -39.70K | 46.00K | -1.02M |
| Income Tax Expenses | 119.00K | 181.50K | 186.20K | 183.10K | 214.10K |
| Earnings from Continuing Operations | -0.50 | 0.00 | -0.23 | -0.14 | -1.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -131.30K | -58.40K | 12.90K | 62.50K | 94.10K |
| Net Income | -629.30K | -54.20K | -213.20K | -74.80K | -1.14M |
| EBIT | 835.30K | 732.80K | 474.10K | 328.70K | 240.30K |
| EBITDA | 2.31M | 2.25M | 2.04M | 1.93M | 1.83M |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.00 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.02 | 0.00 | -0.01 | 0.00 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 225.29M | 225.16M | 224.51M | 220.43M | 214.45M |
| Average Diluted Shares Outstanding | 226.09M | 225.98M | 225.26M | 221.07M | 215.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
